Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;15(8):1221.
doi: 10.3390/life15081221.

Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up

Affiliations

Laboratory, Clinical, and Pathohistological Significance of the Outcomes of Patients with Membranous Nephropathy After 10 Year of Follow-Up

Marko Baralić et al. Life (Basel). .

Abstract

Membranous nephropathy (MN) is the most prevalent cause of nephrotic syndrome (NS) in adults, and it can be primary (idiopathic) with an unknown cause or secondary due to a variety of conditions (lupus, infections, malignancies, medications, etc.). It progresses to chronic kidney disease (CKD) in up to 60% of patients, and 10 to 30% develop end-stage kidney disease (ESKD). This retrospective study examines the importance of specific factors, including baseline demographic and clinical data, kidney biopsy PH findings, and selected biochemical parameters, influencing MN outcomes after 10 years of follow-up. The cohort included 94 individuals in whom a diagnosis of MN was established by percutaneous biopsy of the left kidney's lower pole at the University Clinical Center of Serbia (UCCS) between 2008 and 2013. According to the outcomes, patients were divided into three groups: the recovery (Rec) group, with complete remission, including normal serum creatinine (Scr) and proteinuria (Prt), the group with development of chronic kidney disease (CKD), and the group with development of end-stage kidney disease (ESKD). Nephropathologists graded pathohistological (PH) results from I to III based on the observed PH findings. During the follow-up period, 33 patients were in the Rec group, CKD developed in 53 patients, and ESKD developed in 8 patients. Baseline creatinine clearance levels (Ccr), Scr, and uric acid (urate) were found to be significantly associated with the outcomes (p < 0.001). The lowest values of baseline Scr and urate were observed in the Rec group. The presence of acute kidney injury (AKI) or CKD at the time of kidney biopsy was associated with the more frequent development of ESKD (p = 0.02). Lower Ccr was associated with a higher likelihood of progressing to CKD (B = -0.021, p = 0.014), whereas older age independently predicted progression to ESKD (B = 0.02, p = 0.032). Based on this study, it was concluded that the most important biochemical and clinical factors that are associated with the outcomes of this disease are the values of Scr, Ccr, and urate and the existence of CKD at the time of kidney biopsy. Unlike most previous studies, the presence of HTN had no statistical significance in the outcome of the disease.

Keywords: chronic kidney disease; hypertension; membranous nephropathy; proteinuria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Mechanism of MN and clinical presentation of the disease.
Figure 2
Figure 2
The most common therapeutic modalities for treating MN and the mechanism of therapeutic action.
Figure 3
Figure 3
The PH findings included the number of glomeruli, the pattern and type of GBM thickening, the type of deposit on the GBM, and the grade of the disease according to established criteria.

References

    1. Keri K.-C., Blumenthal S., Kulkarni V., Beck L., Chongkrairatanakul T. Primary membranous nephropathy: Comprehensive review and historical perspective. Postgrad. Med. J. 2019;95:23–31. doi: 10.1136/postgradmedj-2018-135729. - DOI - PubMed
    1. Couser W.-G. Primary Membranous Nephropathy. Clin. J. Am. Soc. Nephrol. 2017;12:983–997. doi: 10.2215/CJN.11761116. Erratum in Clin. J. Am. Soc. Nephrol. 2017, 12, 1528. - DOI - PMC - PubMed
    1. Xie J., Liu L., Mladkova N., Li Y., Ren H., Wang W., Cui Z., Lin L., Hu X., Yu X., et al. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat. Commun. 2020;11:1600. doi: 10.1038/s41467-020-15383-w. - DOI - PMC - PubMed
    1. Saeed M., Beggs M.L., Walker P.D., Larsen C.P. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes. Genes Immun. 2014;15:556–561. doi: 10.1038/gene.2014.50. - DOI - PubMed
    1. Miao H., Wang Y.N., Su W., Zou L., Zhuang S.G., Yu X.Y., Liu F., Zhao Y.Y. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway. Acta Pharmacol. Sin. 2024;45:137–149. doi: 10.1038/s41401-023-01148-w. - DOI - PMC - PubMed

LinkOut - more resources